Aravive Inc (NASDAQ:ARAV)
| 2.08 Delayed Data As of 4:00pm ET |  +0.08 / +4.00%Today’s Change | 0.58 Today|||52-Week Range 2.40 | +57.58% Year-to-Date |
Latest ARAV News | Press Releases
No recent news for Aravive Inc.
Today’s Trading
| Previous close | 2.00 |
| Today’s open | 2.00 |
| Day’s range | 1.92 - 2.15 |
| Volume | 7,955 |
| Average volume (3 months) | 475,157 |
| Market cap | $102.3M |
Data as of 4:00pm ET, 02/07/2023
Growth & Valuation
| Earnings growth (last year) | -0.85% |
| Earnings growth (this year) | +4.05% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +30.91% |
| P/E ratio | NM |
| Price/Sales | 5.91 |
| Price/Book | 0.85 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| XFORX4 Pharmaceuticals I... | -0.02 | -1.77% |
| MREOMereo Biopharma Grou... | -0.02 | -2.16% |
| XBITXBiotech Inc | -0.07 | -1.69% |
| ---- |
Data as of 3:59pm ET, 02/07/2023
Financials
| Next reporting date | March 31, 2023 |
| EPS forecast (this quarter) | -$0.33 |
| Annual revenue (last year) | $7.4M |
| Annual profit (last year) | -$39.2M |
| Net profit margin | -526.08% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Houston, Texas |
Forecasts
